Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2015).
Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence.
Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Sci. Pharm. 2010, 78(3), 718; https://doi.org/10.3797/scipharm.cespt.8.POT03 (registering DOI)
A Coupled Kinetic-Dynamic Model Characterising Cell Cycle Response to an Anti-Cancer Agent
School of Engineering, University of Warwick, Coventry, United Kingdom
University of Wales College of Medicine, Cardiff University, Cardiff, United Kingdom
Author to whom correspondence should be addressed.
Received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010
Abstract Topotecan (TPT) is a semi-synthetic derivative of the natural extract camptothecin, which has been found to act as an inhibitor of the DNA enzyme topoisomerase I in a specific and reversible fashion. [...]
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
ATARI, M.I.; CHAPPELL, M.J.; ERRINGTON, R.J.; SMITH, P.J.; EVANS, N.D. A Coupled Kinetic-Dynamic Model Characterising Cell Cycle Response to an Anti-Cancer Agent. Sci. Pharm. 2010, 78, 718.
ATARI MI, CHAPPELL MJ, ERRINGTON RJ, SMITH PJ, EVANS ND. A Coupled Kinetic-Dynamic Model Characterising Cell Cycle Response to an Anti-Cancer Agent. Scientia Pharmaceutica. 2010; 78(3):718.
ATARI, M. I.; CHAPPELL, M. J.; ERRINGTON, R. J.; SMITH, P. J.; EVANS, N. D. 2010. "A Coupled Kinetic-Dynamic Model Characterising Cell Cycle Response to an Anti-Cancer Agent." Sci. Pharm. 78, no. 3: 718.
Show more citation formats
Show less citations formats
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.